Matches in Wikidata for { <http://www.wikidata.org/entity/Q64223139> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q64223139 description "assaig clínic" @default.
- Q64223139 description "clinical trial" @default.
- Q64223139 description "clinical trial" @default.
- Q64223139 description "clinical trial" @default.
- Q64223139 description "clinical trial" @default.
- Q64223139 description "ensaio clínico" @default.
- Q64223139 description "ensayo clínico" @default.
- Q64223139 description "ensayu clínicu" @default.
- Q64223139 description "essai clinique" @default.
- Q64223139 description "klinisch onderzoek" @default.
- Q64223139 description "клінічне випробування" @default.
- Q64223139 name "Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer" @default.
- Q64223139 type Item @default.
- Q64223139 label "Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer" @default.
- Q64223139 prefLabel "Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer" @default.
- Q64223139 P1132 Q64223139-4561C798-0BD0-4536-8FD8-E7BD0F97E876 @default.
- Q64223139 P1476 Q64223139-F8EE2A24-0CC8-4D5D-BFA7-34F4124E1375 @default.
- Q64223139 P17 Q64223139-0559E5D3-88EC-4C9D-AC9B-1481D54391F4 @default.
- Q64223139 P17 Q64223139-2B035346-87CC-43EC-91D3-7A2A57DFE729 @default.
- Q64223139 P17 Q64223139-4A8D8A0A-4A47-43A9-8E5E-6CA9AB44F4FB @default.
- Q64223139 P17 Q64223139-9858C301-457F-423C-916E-7C7221239CCC @default.
- Q64223139 P17 Q64223139-B6951236-2821-466F-9239-58296E5BE211 @default.
- Q64223139 P17 Q64223139-E844EE50-9DC2-4C5A-BB86-CF46AAD2FF58 @default.
- Q64223139 P1813 Q64223139-3BA3BC6D-1D0E-4ED7-BD98-905A2569D0F7 @default.
- Q64223139 P2899 Q64223139-7C82DE8F-EE36-4557-8E75-CC446DC1C9C5 @default.
- Q64223139 P3098 Q64223139-8160D86F-9009-4439-9131-2DF30FB9BC1A @default.
- Q64223139 P31 Q64223139-E7562ACA-EC1B-45DA-81CF-43AA62A65AD9 @default.
- Q64223139 P4844 Q64223139-E74E5146-3E8C-4177-B51C-7C83607836AC @default.
- Q64223139 P580 Q64223139-730295B9-F9A1-4455-8226-8B77846E7D9D @default.
- Q64223139 P582 Q64223139-AF634314-01C6-4CA8-91BA-0C0F76CE2E14 @default.
- Q64223139 P8363 Q64223139-C99B03F0-25CB-4B5D-B366-1BBEBCE90C0A @default.
- Q64223139 P1132 "+111" @default.
- Q64223139 P1476 "An Open-label, Randomized, Multi-center, Single-Dose, 2-Sequence, 2-Period, Crossover, Comparative Bioequivalence Study of IG-001 (Cb-paclitaxel) 260 mg/m2 Versus Nab-paclitaxel 260 mg/m2 Administered Intravenously With an Open-Label Extension of IG-001 in Patients With Metastatic or Locally Recurrent Breast Cancer" @default.
- Q64223139 P17 Q212 @default.
- Q64223139 P17 Q218 @default.
- Q64223139 P17 Q230 @default.
- Q64223139 P17 Q30 @default.
- Q64223139 P17 Q334 @default.
- Q64223139 P17 Q403 @default.
- Q64223139 P1813 "TRIBECA" @default.
- Q64223139 P2899 "+30" @default.
- Q64223139 P3098 "NCT02064829" @default.
- Q64223139 P31 Q30612 @default.
- Q64223139 P4844 Q423762 @default.
- Q64223139 P580 "2014-03-01T00:00:00Z" @default.
- Q64223139 P582 "2015-02-01T00:00:00Z" @default.
- Q64223139 P8363 Q78089383 @default.